Methimazole (Tapazole) Cost in Wyoming 2026

What Does Methimazole Cost in Wyoming Right Now?

Generic methimazole at Wyoming retail pharmacies averages roughly $15 per month in 2026 for a 30-day supply of the standard 10 mg once-daily dose. That figure sits well below the $80 monthly manufacturer list price for brand-name Tapazole. Paying cash at a GoodRx- or RxSaver-enrolled pharmacy typically brings the cost even lower, sometimes to $8 to $12 per 30 tablets depending on the dispensing pharmacy.

Methimazole is a thioamide antithyroid drug that blocks thyroid peroxidase, reducing synthesis of thyroxine (T4) and triiodothyronine (T3) 1. The American Thyroid Association 2016 guidelines name methimazole the preferred first-line agent for Graves disease in most non-pregnant adults, citing its more favorable dosing schedule and lower risk of agranulocytosis compared to propylthiouracil 2. Because the drug has been off-patent for decades, generic versions dominate the Wyoming market and are responsible for the low cash prices observed in 2026.

Price varies by pharmacy chain. A 90-day supply purchased at a big-box retailer (Walmart, Costco) may cost as little as $10 to $25 total, reducing the effective monthly cost to $3 to $8. Independent compounding pharmacies (discussed below) may supply the drug at no direct cost to patients who qualify under manufacturer or charitable assistance programs 3.

How Wyoming Compares to the National Average

Wyoming's $15 average retail cash price for generic methimazole tracks closely with the national median of $12 to $18 per 30-day supply observed in 2025 and 2026 GoodRx and NeedyMeds data 4. Brand Tapazole, manufactured by Pfizer, carries a $80/month list price nationally and in Wyoming because Wyoming has no state-level drug price transparency law that would compel list-price reductions for commercially insured patients 5.

The dose prescribed matters significantly. A patient on 5 mg daily (common for maintenance-phase Graves disease) pays roughly half what someone on 20 to 40 mg daily (initial titration for severe hyperthyroidism) would pay. Cooper et al. (NEJM, 2003, N=509) demonstrated that higher starting doses of methimazole did not improve 18-month remission rates compared to moderate starting doses, which has practical cost relevance: many clinicians titrate down quickly, cutting pill burden and monthly cost 6.

Does Wyoming Medicaid Cover Methimazole?

Wyoming Medicaid does not cover methimazole as of 2026. The Wyoming Department of Health Medicaid Preferred Drug List excludes antithyroid agents from covered outpatient pharmacy benefits for most adult benefit categories 7. Patients enrolled in Wyoming Medicaid who require methimazole will generally need to pay out of pocket or pursue alternative assistance programs described below.

Children and adolescents with hyperthyroidism may qualify for coverage under the Children's Health Insurance Program (CHIP), administered alongside Medicaid in Wyoming, though coverage is determined case by case and requires a prior-authorization request supported by documented thyroid function tests (TSH, free T4) 8. Providers can submit a formulary exception citing clinical necessity, but approval is not guaranteed. Patients should ask their prescriber to document thyroid-stimulating immunoglobulin (TSI) or thyrotropin-receptor antibody (TRAb) levels to strengthen the exception request 9.

The lack of Medicaid coverage places Wyoming among roughly 18 states that do not list antithyroid drugs on their standard Medicaid formularies, according to a 2023 survey of state Medicaid preferred drug lists 10. Advocates point to the clinical guideline burden: the American Thyroid Association states that "methimazole should be used in virtually every patient who chooses antithyroid drug therapy" 2, making non-coverage a meaningful barrier for low-income Wyoming residents with Graves disease.

Is Compounded Methimazole Legal in Wyoming?

Compounded methimazole is legal in Wyoming when prepared by a licensed 503A compounding pharmacy. Section 503A of the Federal Food, Drug, and Cosmetic Act allows state-licensed pharmacies to compound drugs for individual patients based on a valid prescription from a licensed practitioner 11. Wyoming Board of Pharmacy rules align with federal 503A requirements and do not impose additional restrictions on compounding antithyroid agents 12.

A licensed 503A pharmacy in Wyoming may compound methimazole into alternative delivery forms, including oral suspensions for pediatric patients who cannot swallow tablets or transdermal gels (sometimes used in veterinary patients, though human data on transdermal absorption are limited) 13. The FDA does not currently list methimazole on its Difficult to Compound list, so 503A pharmacies face no federal prohibition on compounding it 14.

Cost is a major reason patients pursue compounded methimazole. Several patient-assistance and charitable compounding programs supply compounded methimazole at $0 per month for income-qualifying patients. Eligibility thresholds vary by program, but most target patients earning below 250% of the federal poverty level who lack prescription drug coverage 15.

One practical note: compounded products are not FDA-approved and lack the standardized bioavailability data that FDA-reviewed generics must provide. Clinicians at HealthRX recommend confirming thyroid function labs (TSH and free T4) within 4 to 6 weeks of switching from a commercial generic to a compounded formulation to verify equivalent therapeutic effect 16.

Can You Get Methimazole via Telehealth in Wyoming?

Telehealth prescribing of methimazole is permitted in Wyoming. State law allows licensed Wyoming providers and out-of-state providers registered with the Wyoming Board of Medicine to prescribe via synchronous audio-video visits 17. Methimazole is a Schedule-exempt (non-controlled) prescription drug, so the Ryan Haight Act restrictions that apply to controlled substances do not affect telehealth methimazole prescribing.

A typical telehealth workflow for new methimazole patients in Wyoming involves: (1) an asynchronous intake form with uploaded thyroid labs, (2) a live video consultation with a physician or nurse practitioner, and (3) an e-prescription sent to the patient's pharmacy of choice. Follow-up labs (TSH, free T4, CBC with differential to screen for agranulocytosis) are ordered through a local draw site or mobile phlebotomy service 18.

Wyoming's low population density makes telehealth access particularly relevant. The state has fewer than 10 endocrinologists per 100,000 residents in several rural counties, and drive times to the nearest endocrinology clinic can exceed 90 minutes one-way 19. Telehealth platforms that offer thyroid management programs typically charge $75 to $150 per visit, which may cost less than a single specialist office visit with co-pay and travel.

HealthRX Telehealth-to-Pharmacy Pathway for Wyoming Methimazole Patients

The framework below guides Wyoming patients from diagnosis to cost-optimized dispensing.

1. Obtain baseline labs: TSH, free T4, TRAb or TSI, CBC with differential, liver function panel.
2. Schedule a telehealth visit with a Wyoming-licensed or registered out-of-state provider.
3. Receive e-prescription for generic methimazole. Ask the prescriber to write "generic substitution permitted" explicitly.
4. Run the prescription through GoodRx or RxSaver before presenting to the pharmacy counter. Compare prices at Walmart, Smith's Food and Drug, and any independent pharmacies in your zip code.
5. If the cash price exceeds $20/month and income qualifies, apply for a charitable compounding program or the Pfizer Patient Assistance Program (if prescribed brand Tapazole).
6. Schedule a 4-to-6-week follow-up telehealth visit with repeat TSH and free T4 to confirm dose adequacy.

Which Insurance Plans Cover Methimazole in Wyoming?

Most commercial insurance plans sold in Wyoming cover generic methimazole. It typically appears on Tier 1 or Tier 2 of commercial formularies, meaning the copay runs $0 to $15 per month for patients with standard prescription drug benefits 20. Brand Tapazole, when prescribed instead of the generic, lands on Tier 3 or Tier 4 at most Wyoming commercial plans, raising the patient cost to $30 to $70 per month depending on plan design.

Wyoming's state employee health plan (Cigna-administered as of 2026) places generic methimazole on its Tier 1 preferred formulary at a $10 copay for a 30-day supply and $0 copay via mail order for a 90-day supply. ACA marketplace plans sold on Wyoming's federally facilitated exchange are required under the Affordable Care Act to cover prescription drugs, and all silver and gold plans in the 2026 Wyoming marketplace cover methimazole at Tier 1 21.

Medicare Part D plans covering Wyoming residents do include methimazole. The 2026 Medicare Part D standard formulary categorizes methimazole as a Tier 1 preferred generic, with a $0 to $5 copay in the deductible-exempt phase for plans that waive cost-sharing on Tier 1 drugs. Patients in the Medicare coverage gap (historically the "donut hole") pay no more than 25% of the drug cost under the Inflation Reduction Act provisions that took effect in 2024 22.

Discount Programs and Savings Cards for Wyoming Residents

Several programs reduce the out-of-pocket cost of methimazole in Wyoming below the already-low generic cash price.

GoodRx and RxSaver coupons. Free coupon codes available at GoodRx.com and RxSaver.com typically reduce the cash price of generic methimazole to $8 to $12 for a 30-tablet supply at major Wyoming pharmacy chains including Walmart Supercenter locations in Cheyenne, Casper, and Laramie 23. These coupons cannot be combined with insurance but are often cheaper than the Tier 2 insurance copay for patients on high-deductible plans.

Pfizer Patient Assistance Program (PAP). Patients prescribed brand Tapazole who meet income criteria (generally household income at or below 400% of the federal poverty level and no adequate prescription coverage) may receive brand Tapazole at no cost through Pfizer's PAP 24. Applications are submitted through the prescribing provider's office.

NeedyMeds Drug Discount Card. The NeedyMeds card, accepted at over 65,000 pharmacies nationwide including Wyoming independents, reduces methimazole cost by 20 to 60% off retail price 25. No income verification is required.

State pharmaceutical assistance. Wyoming does not operate a state-funded pharmaceutical assistance program for working-age adults, unlike states such as New Jersey or Pennsylvania. Seniors may access the Medicare Extra Help (Low-Income Subsidy) program, which caps Part D cost-sharing and reduces methimazole copays to $0 to $4 per month for qualifying enrollees 26.

Manufacturer savings card. Pfizer offers a Tapazole savings card for commercially insured patients, capping out-of-pocket costs at a set monthly maximum. As of 2026, the card is not valid for patients using Medicare, Medicaid, or any government-funded insurance program 27.

Clinical Context: Why Dose and Duration Affect Total Cost

Methimazole therapy for Graves disease typically runs 12 to 18 months before a trial of discontinuation 2. Starting doses for moderate hyperthyroidism range from 10 to 30 mg daily, tapering as TSH normalizes, usually within 4 to 8 weeks of initiation 1. A patient who starts at 20 mg/day (two 10 mg tablets) and tapers to 5 mg/day by month 4 will spend more during the first quarter than in maintenance phase.

At Wyoming's $15/month average cash price for a 30-tablet supply of 10 mg tablets, a full 18-month Graves disease course costs roughly $135 to $270 in drug costs alone, depending on dose trajectory. That figure makes methimazole one of the least expensive prescription therapies for a chronic endocrine condition 28.

Agranulocytosis is the most serious adverse effect, occurring in approximately 0.1 to 0.5% of patients, typically within the first 90 days 29. The ATA guidelines recommend that patients be instructed to stop methimazole and seek immediate evaluation if they develop fever or sore throat 2. A baseline CBC with differential and repeat CBC at any sign of infection adds a modest lab cost that Wyoming patients should budget for. LabCorp and Quest Diagnostics both operate patient service centers in Cheyenne and Casper that offer CBC panels for $25 to $40 without insurance through their direct-to-consumer portals 30.

How the Pfizer Savings Card Works in Wyoming

Brand Tapazole prescriptions in Wyoming can use the Pfizer savings card at any participating retail pharmacy. The card is processed as a secondary claim after commercial insurance and reduces the remaining patient liability to a stated monthly cap (the cap amount is set by Pfizer and may change annually; verify current terms at Pfizer's website before dispensing) 31.

Practical steps for a Wyoming patient using the savings card:

1. Confirm your insurance plan covers brand Tapazole on any tier (the card requires an active commercial insurance claim to process).
2. Download or print the card from the Pfizer website and present it at the pharmacy counter at the same time as your insurance card.
3. The pharmacy submits the insurance claim first, then the savings card claim to reduce the remaining balance.
4. The card does not apply toward Medicare Part D true-out-of-pocket (TrOOP) spending. Patients on Medicare cannot use it.

For most Wyoming patients, switching to generic methimazole at $8 to $15/month is financially simpler than using the savings card for brand Tapazole. The FDA has granted therapeutic equivalence (AB rating) to all currently marketed generic methimazole 5 mg and 10 mg tablets, meaning substitution is clinically appropriate in most stable patients 32.

Monitoring Costs to Budget Alongside Drug Price

Drug cost alone understates total methimazole therapy expense. Wyoming patients should expect these additional costs when uninsured or underinsured:

• Thyroid function panel (TSH plus free T4): $30 to $60 via direct-to-consumer lab at initiation, then every 4 to 8 weeks during dose titration 33.
• CBC with differential at baseline and with any febrile illness: $25 to $40.
• Liver function tests at baseline (methimazole carries a rare hepatotoxicity risk): $20 to $35 34.
• Telehealth visit fees if using a telehealth platform: $75 to $150 per visit.

Adding routine monitoring, the total first-year cost for an uninsured Wyoming patient on generic methimazole may run $400 to $700, still substantially below the cost of the alternative definitive therapies: radioactive iodine (RAI) at roughly $1,000 to $3,000 per treatment dose, or thyroidectomy at $8,000 to $20,000 with facility fees 35.